Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients.
PHASE2
This is a prospective, phase 2, multicenter, open-label, single-arm study. ...
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
PHASE1
This study will evaluate the safety, efficacy, and pharmacokinetics of indu...
Status
Completed
Location
Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital